Variable | Kosovo (n = 100) | Croatia (n = 113) | All (213) |
---|---|---|---|
Age | |||
< 40 years | 12 | 11 | 23 |
≥ 40 years | 88 | 102 | 190 |
Premenopausal | 33 | 37 | 70 |
Postmenopausal | 67 | 76 | 143 |
Histological type | |||
IDC (NST) | 76 | 89 | 165 |
ILC | 16 | 14 | 20 |
Other | 18 | 10 | 28 |
Axillary involvement | |||
Yes | 47 | 39 | 86 |
No | 53 | 74 | 127 |
pN( +) status | |||
N0 | 53 | 75 | 128 |
N1 | 20 | 27 | 47 |
N2 | 17 | 9 | 26 |
N3 | 10 | 2 | 12 |
Stage | |||
I | 19 | 58 | 77 |
II | 54 | 43 | 97 |
III | 29 | 10 | 39 |
Histological grade | |||
G1 | 3 | 10 | 13 |
G2 | 69 | 69 | 138 |
G3 | 28 | 34 | 62 |
Ki-67% | |||
< 20 | 41 | 49 | 90 |
> 20 | 59 | 64 | 123 |
ER status | |||
ER + | 77 | 92 | 169 |
ER − | 23 | 21 | 44 |
PR status | |||
PR + | 20 | 45 | 65 |
PR − | 80 | 68 | 148 |
Her2/new status | |||
Her 2( +) | 24 | 16 | 40 |
Her 2( −) | 76 | 97 | 173 |
LVI status | |||
Positive | 52 | 20 | 72 |
Negative | 48 | 93 | 141 |
Metastatic lymph nodes | |||
Positive | 47 | 38 | 85 |
Negative | 53 | 75 | 128 |
Molecular subtypes | |||
Lum. A | 35 | 42 | 77 |
Lum. B/Her2 neg | 32 | 43 | 75 |
Lum. B/Her2 poz | 12 | 8 | 20 |
Her2 positive | 11 | 8 | 19 |
Triple negative | 10 | 12 | 22 |
IL-7/median (25–75%) | 66.1 (31.5–183.3) | 54.7 (18.0–134.3) |